Oral Steroids Finasteride Anabolic Hormone for Treatment
|FOB Price:||US $1-45 / Gram|
|Min. Order:||10 Gram|
|Min. Order||FOB Price|
|10 Gram||US $1-45/ Gram|
|Port:||Hong Kong, Hong Kong|
|Payment Terms:||T/T, Western Union, Money Gram, Bitcoin|
- Model NO.: CAS 98319-26-7
- Customized: Customized
- Suitable for: Elderly, Adult
- Purity: >99%
- Mf: C23h36n2o2
- Appearance: off-White Crystalline Powder.
- Transport Package: as Requires
- Origin: China
- Powder: Yes
- Certification: GMP, HSE, ISO 9001, USP, BP
- State: Solid
- Alias: Proscar, Propecia, Fincompared Toteride
- MW: 372.55
- Trademark: Biopharmchem
- Specification: Pharmaceutical Grade
- HS Code: 2933290090
Oral steroids Finasteride anabolic hormone for treatment
Alias: Proscar,Propecia,fincompared toteride
CAS No: 98319-26-7
Appearance: Off-white crystalline powder.
Grade: Pharmaceutical Grade
Finasteride is a synthetic drug for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB). It is a type II 5α-reductase inhibitor. 5α-reductase is an enzyme that converts testosterone to dihydrotestosterone (DHT).
Physicians use finasteride for the treatment of benign prostatic hyperplasia (BPH), informally known as an enlarged prostate. The FDA-approved dose is 5 mg once a day. Six months or more of treatment with finasteride may be required to determine the therapeutic results of treatment. If the drug is discontinued, any therapeutic benefits reverse within about 6-8 months. Finasteride may improve the symptoms associated with BPH such as difficulty urinating, getting up during the night to urinate, hesitation at the start of urination, and decreased urinary flow.
Treatment of Enlarged Prostate Gland:
Finasteride is a very potent type II 5a-reductase inhibitor, which prevents conversion of testosterone to dihydrotestosterone (DHT). DHT is a sex hormone. In addition, it is used for treatment of benign prostatic hyperplasia (BPH), which is the enlargement of the prostate.
Finasteride inhibits 4a-reductase, and as mentioned, will prevent testosterone conversion to DHT. Studies have shown it will reduce serum DHT levels by about 65-70%, and prostate DHT levels, by up to 90%. By blocking DHT production, finasteride reduces androgen activity on the scalp; and in the prostate reduces prostate volume, which improves BPH, and reduces risk of prostate cancer.
|Appearance||White crystalline powder|
|Identification||By UV, To match with working standard||Complies|
|Related Substances||Not more than the reference solution (0.05%)||Complies|
|Loss on drying||<0.5%||0.1%|
|Resiue on ignition||≤0.1%||0.03%|